Odimma Therapeutics
Personalized cancer immunotherapy platform
- B2B
- AI-native
About Odimma Therapeutics
French biotech company focused on personalized cancer immunotherapy, leveraging neoantigens to improve efficacy of current therapies for hard-to-treat cancers Entering clinic soon
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1–10 employees
- Headquarters
- Illkirch-Graffenstaden, Grand Est, France
- Founded
- 2017
- Revenue
- $2.6M – $20.2MTamtam estimate
- Website
- odimma-therapeutics.com
- linkedin.com/company/odimma
Odimma Therapeutics at a glance
Odimma Therapeutics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Illkirch-Graffenstaden, Grand Est, France.
Odimma Therapeutics was founded in 2017.
Odimma Therapeutics has 1–10 employees.
Odimma Therapeutics's revenue is $2.6M – $20.2M (Tamtam estimate).
Frequently asked questions about Odimma Therapeutics
What is Odimma Therapeutics's revenue?
Tamtam estimates Odimma Therapeutics's annual revenue at $2.6M – $20.2M.
How many employees does Odimma Therapeutics have?
Odimma Therapeutics has 1–10 employees.
Where is Odimma Therapeutics headquartered?
Odimma Therapeutics is headquartered in Illkirch-Graffenstaden, Grand Est, France.
Selling to companies like Odimma Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies